YOLFTbeta
Phytohealth Corp

Phytohealth Corp

4108 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

10.40TWD+0.10 (+0.97%)

Price History

Full chart

Market Stats

Previous Close10.30
Open10.30
Day Range10.30 – 10.50
52-Week Range10.70 – 15.45
Volume81.45K
Market Cap2.25B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.22
Dividend Yield0.00%
Beta0.35
50-Day Avg11.31
200-Day Avg12.54

About

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. The Medical Diagnosis segment develops and sells smart medical imaging diagnostic products. The Precision Medical Equipment and Instruments segment engages in the research and development, manufacturing, and sale of ultrasound probes and analysis systems. Its products under development include PHN031, which has completed Phase II clinical trials for the treatment of osteoporosis, and PHN033, which has completed Phase II clinical trials for the treatment of diabetic nephropathy. The company is also developing PHN016, which is in Phase II clinical trials for the treatment of cancer, and PHN017, which is in Phase I trials for the treatment of severe infection-induced cytokine storm. In addition, it offers PG2 Lyophilized Injection for the treatment of cancer-related fatigue and capsules for acute moderate to severe pain. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Yi-Li Lee BBA
  • Employees0
  • HeadquartersNo.167, Fuxing North Road, Taipei, Taiwan, Taiwan
  • Websitehttps://www.phytohealth.com.tw

Leadership

  • Ms. Yi-Li Lee BBAChairman
  • Ms. I-Lin LeeGM & Vice Chairman
  • Chih Yuan HuangFinancial & Accounting Officer
  • Mr. Kevin LinManager of Administration Division
  • Mr. Fred LaiManaging Director
  • Li Feng YehChief Internal Officer
  • Hao Lun NiAssistant Manager for Public Affairs

Financials

Income Statement

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-10.78M39.37M113.88M152.09M204.75M136.43M99.19M107.90M155.09M177.71M144.99M90.73M20.98M25.02M54.00M107.48M95.48M91.81M168.94M135.47M162.49M153.56M134.58M
Growth (%)--+265.17%+189.26%+33.55%+34.63%-33.37%-27.29%+8.78%+43.73%+14.58%-18.41%-37.42%-76.88%+19.27%+115.80%+99.06%-11.16%-3.85%+84.01%-19.81%+19.95%-5.49%-12.36%
Cost of Revenue---94.74M88.55M37.40M93.57M87.39M98.61M144.42M161.91M146.38M88.89M18.27M12.53M29.78M52.42M31.91M46.31M90.62M78.43M94.85M89.56M93.28M
Gross Profit-------11.80M9.29M10.67M15.80M-1.39M1.84M2.70M12.49M24.21M55.07M63.58M45.50M78.31M57.03M67.64M64.01M41.29M
Gross Margin-------11.89%8.61%6.88%8.89%-0.96%2.03%12.89%49.92%44.84%51.23%66.59%49.56%46.36%42.10%41.63%41.68%30.68%
Operating Expense-------255.38M227.97M204.11M153.54M238.96M347.54M269.15M251.72M292.57M323.90M268.17M161.42M173.52M171.49M189.32M224.19M215.87M
Operating Income----31.54M18.80M--243.58M-218.68M-193.44M-137.74M-240.35M-345.70M-266.45M-239.23M-268.35M-268.83M-204.59M-115.92M-95.21M-114.46M-121.68M-160.18M-174.58M
Operating Margin----20.74%9.18%--245.56%-202.66%-124.73%-77.51%-165.78%-381.01%-1270.14%-956.12%-496.99%-250.12%-214.27%-126.26%-56.36%-84.49%-74.88%-104.31%-129.73%
EBITDA--------245.61M-197.31M-172.33M-90.93M-143.97M-293.92M-218.51M-190.58M-193.73M-153.88M-139.42M-61.13M-42.30M-61.97M-20.70M-54.86M-60.66M
EBITDA Margin--------247.61%-182.86%-111.12%-51.17%-99.30%-323.94%-1041.60%-761.68%-358.78%-143.16%-146.01%-66.58%-25.04%-45.75%-12.74%-35.72%-45.08%
Net Income---2.18M11.54M26.73M--267.05M-215.12M-170.07M-103.79M-182.96M-321.70M-203.50M-194.52M-206.35M-182.48M-170.93M-118.66M-78.02M-115.03M-47.12M-73.50M-58.20M
Net Income Margin---1.92%7.59%13.05%--269.23%-199.36%-109.66%-58.41%-126.19%-354.56%-970.06%-777.41%-382.16%-169.77%-179.01%-129.24%-46.18%-84.92%-29.00%-47.86%-43.25%
R&D-----73.38M123.55M208.63M171.56M163.50M89.94M176.53M263.38M175.27M161.61M146.14M168.00M164.07M124.72M120.47M119.52M92.59M128.51M119.35M
R&D as % of Total Revenue-----35.84%90.56%210.33%158.99%105.42%50.61%121.75%290.28%835.49%645.91%270.65%156.30%171.83%135.85%71.31%88.23%56.98%83.68%88.69%
Interest Expense0000000141.00K00170.00K00000158.00K268.00K240.00K405.00K312.00K344.00K335.00K376.00K
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%0.00%0.00%0.14%0.00%0.00%0.10%0.00%0.00%0.00%0.00%0.00%0.15%0.28%0.26%0.24%0.23%0.21%0.22%0.28%

Balance Sheet

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets156.02M344.09M305.18M1.21B1.35B1.56B1.08B2.11B1.91B1.65B2.88B2.82B2.49B2.34B2.42B2.19B2.07B1.88B1.81B2.47B2.36B2.35B2.44B2.35B
Total Liabilities10.00M12.05M10.87M22.51M30.92M35.99M73.36M102.63M84.67M87.55M100.38M84.59M100.75M43.20M109.61M114.71M123.53M130.20M107.47M81.56M87.17M79.85M71.29M59.42M
Total Equity146.02M332.05M294.31M1.19B1.32B1.39B844.42M1.96B1.78B1.53B2.75B2.57B2.24B2.06B1.88B1.68B1.46B1.30B1.28B1.98B1.91B1.93B1.90B1.87B
Cash42.54M6.89M4.95M703.61M320.73M29.60M261.55M240.06M330.64M361.98M1.56B94.22M46.60M807.25M271.35M73.52M136.00M110.25M61.16M94.01M100.46M62.76M22.72M86.80M
Total Debt--------50.00K-1.81M5.00K60.00K578.00K-298.00K541.00K15.77M17.28M30.93M30.19M28.11M18.34M15.73M
Net Debt--------240.06M-330.59M-361.98M-1.56B-94.21M-46.55M-806.67M-271.35M-73.23M-135.46M-94.48M-43.88M-63.07M-70.27M-34.64M-4.38M-71.07M

Cash Flow

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---59.85M86.57M---107.15M-193.06M-171.09M-164.37M-123.18M-33.74M-131.22M-756.87M-151.52M-141.44M-121.45M-147.87M-68.24M-59.95M-54.77M-50.13M-39.72M
Investing Cash Flow860.00K-2.31M31.44M--207.42M-1.12B94.44M196.13M121.76M-91.75M-13.84M-37.27M-23.16M-46.83M152.81M102.77M109.70M-581.14M76.92M26.25M-135.14M114.82M
Financing Cash Flow-225.00M-600.00M18.77M96.39M56.66M1.20B193.74M6.03M1.24B196.80M166.53M183.13M244.14M520.00K51.10M-7.07M-10.93M682.23M-10.52M-9.18M145.24M-11.04M
Capital Expenditure1.31M632.00K2.00M383.00K60.00K1.15M1.08M223.68M139.53M170.63M49.23M25.10M24.13M20.71M23.16M32.90M64.09M7.03M1.53M13.22M1.60M4.91M5.04M5.54M
Free Cash Flow--------330.83M-332.59M-341.71M-213.59M-148.28M-57.87M-151.93M-780.03M-184.42M-205.53M-128.48M-149.40M-81.45M-61.55M-59.50M-55.18M-45.26M
FCF to OCF-------308.76%172.27%199.73%129.95%120.38%171.51%115.78%103.06%121.71%145.31%105.79%101.04%119.37%102.68%108.64%110.06%113.96%

Earnings

Report DateMar 31, 2008Jun 30, 2008Apr 30, 2009Jun 30, 2009Oct 29, 2009Mar 30, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012Apr 15, 2012Jul 31, 2012Oct 30, 2012Feb 26, 2013May 29, 2013Jul 26, 2013Oct 30, 2013Feb 26, 2014Apr 29, 2014Jul 28, 2014Dec 3, 2014Feb 26, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 11, 2016Mar 1, 2017May 4, 2017Aug 9, 2017Nov 10, 2017Feb 27, 2018May 6, 2018Aug 6, 2018Nov 9, 2018Feb 27, 2019May 10, 2019Aug 13, 2019Nov 8, 2019Feb 29, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Feb 22, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Mar 29, 2022May 11, 2022Aug 31, 2022Nov 30, 2022Mar 14, 2023May 10, 2023
EPS Estimate---0.29--0.29-0.36---------0.21-0.18-0.41-0.21--0.12-0.15--0.21-0.19--0.43-0.37-------------------0.24-------------
EPS Actual0.69-0.88-0.51-0.52-0.43-1.21-0.25-0.22-0.34-0.70-0.22-0.21-0.34-0.42-0.19-0.20-0.06-0.310.05-0.18-0.27-0.71-0.21-0.69-0.46-0.59-0.43-0.35-0.21-0.23-0.33-0.31-0.18-0.34-0.24-0.21-0.22-0.55-0.21-0.16-0.23-0.49-0.19-0.14-0.23-0.44-0.210.02-0.17-0.16-0.14-0.130.04-0.17-0.14-0.090.02-0.18-0.04
Surprise---75.86%--48.28%-236.11%--------9.52%-11.11%85.37%-47.62%--50.00%-80.00%-0.00%-263.16%--37.21%-15.90%-------------------83.33%-------------
Timing--Pre-market-Pre-marketPre-market--------After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursPre-market-Pre-marketPre-market-Pre-market-------After-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-------------

Key Statistics & Ratios

Market Cap2.25B
Enterprise Value1.33B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales15.72
Price / Book1.19
EPS-0.22
Book Value9.78
Revenue (TTM)143.43M
Gross Profit (TTM)47.47M
EBITDA-127.59M
Profit Margin-30.24%
Operating Margin-108.37%
Return on Equity-3.99%
Return on Assets-4.33%
Shares Outstanding198.62M
Shares Float157.17M
Beta0.35
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jan 5, 20212819:2734
  • Oct 11, 2012887:852
  • Jun 19, 2009842:835
  • Nov 15, 2005881:858
  • Dec 30, 2002341:325